Skip to search formSkip to main contentSkip to account menu

lurasidone

Known as: Lurasidona, Lurasidonum, N-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinylmethyl)-1-cyclohexylmethyl)-2,3-bicyclo(2.2.1)heptanedicarboximide 
National Institutes of Health

Related topics

Related topics

6 relations
Antipsychotic AgentsLurasidone Hydrochloride 80 MG Oral Tablet [Latuda]Lurasidone:MCnc:Pt:Urine:Qn:ConfirmSchizophrenia Spectrum and Other Psychotic Disorders

Narrower (2)

LatudaLurasidone Hydrochloride

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Neurochemical arguments for the use of dopamine D4 receptor stimulation to improve cognitive impairment associated with schizophrenia
2017
2017
Case Series Reports on Lurasidone-Associated Mania.
antagonist properties. It has moderate affinity for 5-HT1A and α2 receptors and low affinity for muscarinic, histaminic, and… 
2017
2017
P.3.d.008 Cariprazine specificity profile in the treatment of acute schizophrenia: a meta-analysis and meta-regression of randomized-controlled trials
Cariprazine is a new dopamine D2 and D3 receptor partial agonist antipsychotic. Meta-analytic evidence of efficacy in acute… 
2016
2016
GLYX-13 (rapastinel) ameliorates subchronic phencyclidine- and ketamine-induced declarative memory deficits in mice
2016
2016
Effect of lurasidone on meaningful change in health-related quality of life in patients with bipolar depression
Estimate the proportion of lurasidone-treated patients with bipolar depression who achieved a clinically meaningful improvement… 
2016
2016
Dosing patterns and medication adherence in bipolar disorder patients treated with lurasidone: a US retrospective claims database analysis
Background: The aim of this study was to describe dosing patterns and medication adherence among bipolar patients who initiated… 
Review
2013
Review
2013
Asenapine, iloperidone and lurasidone: critical appraisal of the most recently approved pharmacotherapies for schizophrenia in adults
This article reviews the pharmacological profile and published efficacy and tolerability/safety data of iloperidone, asenapine… 
Review
2012
Review
2012
Psychotropic drug effects on gene transcriptomics relevant to Parkinson's disease
Review
2012
Review
2012
New serotonin/dopamine antagonists for the treatment of schizophrenia: are we making real progress?
The introduction of second-generation antipsychotics (SGAs), heralded by clozapine in 1990, represented an important advance in… 
Review
2011
Review
2011
Iloperidone, Asenapine, and Lurasidone: A Brief Overview of 3 New Second-Generation Antipsychotics
Abstract Three new second-generation antipsychotics were approved by the US Food and Drug Administration in 2009 and 2010… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)